loader
Please Wait
Applying Filters...

Annual Sales of Lemborexant reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 11,494Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Dayvigo

PharmaCompass

01

Brand Name : Dayvigo

Lemborexant

arrow
Luxepack
Not Confirmed

02

Brand Name : Dayvigo

Lemborexant

arrow
Luxepack
Not Confirmed

Brand Name : Dayvigo

arrow
Luxepack
Not Confirmed

Lemborexant

Main Therapeutic Indication : Sleep

Currency : USD

2022 Revenue in Millions : 207

2021 Revenue in Millions : 80

Growth (%) : 157

blank

03

Brand Name : Dayvigo

Lemborexant

arrow
Luxepack
Not Confirmed

Brand Name : Dayvigo

arrow
Luxepack
Not Confirmed

Lemborexant

Main Therapeutic Indication : Sleep

Currency : USD

2023 Revenue in Millions : 262

2022 Revenue in Millions : 207

Growth (%) : 42

blank